Hebei General Hospital

Running trials

• Not yet recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

  NCT07900633· Phase 3· Eli Lilly and Company· Source

• Recruiting

  To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus

  NCT07447986· Phase 2· Hangzhou Sumgen Biotech Co., Ltd.· Source

• Recruiting

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

  NCT07110415· Phase 4· SPH Qingdao Growful Pharmacetical Co.,Ltd· Source

• Not yet recruiting

  The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

  NCT07139587· Qingxia Li· Source

• Not yet recruiting

  A Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Inhaled H057 in the Treatment of Acute Exacerbations of Bronchiectasis

  NCT06958861· Phase 2· Shanghai Huilun Pharmaceutical Co., Ltd.· Source

• Recruiting

  A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

  NCT06641466· Phase 3· Pfizer· Source

• Active, not recruiting

  Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

  NCT06806293· Phase 3· AbbVie· Source

• Not yet recruiting

  Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

  NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Source

• Active, not recruiting

  Sympathetic Mapping/ Ablation of Renal Nerves Trial

  NCT02761811· SyMap Medical (Suzhou), Ltd.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease2 recruiting
• Bronchiectasis1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Lupus (SLE)1 recruiting
• Migraine1 recruiting
• Obesity1 recruiting
• Stroke1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

  NCT06241313· Phase 3· AbbVie· Source

• Completed

  A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.

  NCT05810038· Phase 3· Pfizer· Source

• Completed

  Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

  NCT05417841· Beijing Hospital· Source

• Completed

  rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)

  NCT05700591· Phase 3· Tasly Biopharmaceuticals Co., Ltd.· Source

• Completed

  Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale

  NCT05546320· Phase 2· Chinese Academy of Medical Sciences, Fuwai Hospital· Source

• Completed

  A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants

  NCT05371652· Phase 3· Pfizer· Source

• Completed

  Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction

  NCT04944706· Phase 2· Tasly Pharmaceutical Group Co., Ltd· Source

• Completed

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· Phase 3· Novo Nordisk A/S· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Migraine19 works · 6 trials
• Uterine fibroids9 works · 0 trials
• Trigeminal neuralgia4 works · 0 trials